Experience by Indication
Solid Tumors
Central Nervous System (CNS) Tumors
- Anaplastic Astrocytoma
- Glioblastoma
- Primary Central Nervous System Lymphoma (PCNSL)*
- Pediatric Solid Tumors
Thoracic Malignancies
- Non–Small Cell Lung Cancer (NSCLC)
- Lung Adenocarcinoma
- Squamous NSCLC
- Small Cell Lung Cancer (SCLC)
- Neuroendocrine Tumors (Advanced)
Breast and Gynecologic Malignancies
- Breast Cancer
- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
- Endometrial Cancer
- Cervical Cancer
Genitourinary Malignancies
- Prostate Cancer
- Castration-Resistant Prostate Cancer (CRPC)
- Renal Cell Carcinoma (RCC)
- Bladder Cancer
- Urothelial Carcinoma
Gastrointestinal Malignancies
- Colorectal Cancer
- Gastric Cancer
- Pancreatic Cancer
- Hepatocellular Carcinoma (Liver Cancer)
- Gastrointestinal Stromal Tumor (GIST)
Head and Neck Malignancies
- Head and Neck Squamous Cell Carcinoma (HNSCC)
Skin and Soft Tissue Malignancies
- Basal Cell Carcinoma
- Melanoma
- Mucosal Melanoma
Early Phase / Basket Studies
- Phase I Solid Tumors
- Rare Solid Tumors
Hematologic Malignancies
Leukemias
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Chronic Myelomonocytic Leukemia (CMML)
- Acute Myeloid Leukemia (AML)
Lymphomas
- Non-Hodgkin Lymphoma (NHL)
- Follicular Lymphoma (FL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Small Lymphocytic Lymphoma (SLL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Lymphoplasmacytic Lymphoma
- Mature B-Cell Lymphomas
- Peripheral T-Cell Lymphoma (PTCL)
- Cutaneous T-Cell Lymphoma (CTCL)
- Indolent B-Cell Lymphomas
Plasma Cell and Bone Marrow Disorders
- Multiple Myeloma
- Myelodysplastic Syndromes (MDS)
Early Phase / Basket Studies
- Phase I Hematologic Malignancies
Non-Oncology / Supportive Care
- Mild Respiratory Distress**
Experience by Drug Modalities
- Antiangiogenic small molecules
- Antigen Presenting Cell (APC)
- Anti-metabolite
- Antibody Drug Conjugates (ADC)
- Biomarker
- Chemotherapy
- Cytotoxics
- Fusion proteins / Engineered biologics
- Gene therapies
- Glutaminase inhibitors
- Hormones
- Hedgehog pathway inhibitors
- Immunotherapeutic product obtained from leukapheresis
- Monoclonal antibodies (mAb)
- Live biotherapeutic product (LBP)
- Oncologic vaccine
- Oligonucleotide
- Opioid
- Oxygen carriers / Nanoparticles
- Peptides
- Photosensitizing agent
- Radiopharmaceuticals
- Radioactive imaging agent
- Radioligand Therapeutics
- Recombinant DNA (single-strand DNA)
- Retroviral replicating vector
- Small molecules
- (Stem) cell therapies
- Vaccines
Clinical Team Experience
- Solid tumors / hematologic malignancies
- Registrational trials
- Dose escalation / first-in-human studies
- Basket trials
- Biomarker-driven patient selection
- Radionuclide therapeutics products
- Radiopharmacies
- Rare diseases
- Pediatric population
- Inspections by regulatory agencies


